SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)
NCT ID: NCT04487197
Last Updated: 2021-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
282 participants
OBSERVATIONAL
2020-07-15
2021-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal
NCT05808192
Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases
NCT04420637
Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis
NCT06566638
Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation
NCT05051605
Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)
NCT00802555
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort 1
* Adult patients (age ≥ 18 years),
* kidney or pancreas or pancreatic islets transplantation
* transplanted patients (period: 01.01.2020 to 30.06.2020)
blood sample for seroepidemiological investigation
blood sample for seroepidemiological investigation
Cohort 2
* Adult patients (age ≥ 18 years),
* kidney or pancreas or pancreatic islets transplantation
* Transplanted patients in follow-up since 01.01.2020 or trasplanted patients after 30.06.2020.
blood sample for seroepidemiological investigation
blood sample for seroepidemiological investigation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood sample for seroepidemiological investigation
blood sample for seroepidemiological investigation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Kidney or pancreas or pancreatic islets transplantation
* Transplanted patients (period: 01.01.2020 to 30.06.2020)
* Informed Consent signed
* Adult patients (age ≥ 18 years),
* Kidney or pancreas or pancreatic islets transplantation
* transplanted patients in follow-up since 01.01.2020 or trasplanted patients after 30.06.2020.
* Informed Consent signed
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Antonio Secchi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Secchi
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS San Raffaele
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID-SIERO TRAPIANTI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.